Company / Current Assets per Share
ORAMED PHARMACEUTICALS INC. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$3.34
FY2025
5-year range
$3.34 / $4.12
FY2021-FY2025
Trend
-6.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has declined for 3 consecutive years, from $4.12 in FY2022 to $3.34 in FY2025.
Based on SEC 10-K filings.
3.34 in FY2025 with a 5-year CAGR of +7.5%.
Declined from $4.11 to $3.34 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -6.8%
- 5-Year CAGR
- +7.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- ORAMED PHARMACEUTICALS INC.'s current assets per share has declined for 3 consecutive years.
- In FY2025, current assets per share decreased 6.0% year-over-year.
- Peak current assets per share was recorded in FY2022.
- Lowest current assets per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.34 | -6.0% |
| FY2024 | $3.55 | -13.6% |
| FY2023 | $4.11 | -0.2% |
| FY2022 | $4.12 | +2.2% |
| FY2021 | $4.03 | +72.8% |
| FY2020 | $2.33 | +21.5% |
| FY2019 | $1.92 | -15.5% |
| FY2018 | $2.27 | +47.5% |
| FY2017 | $1.54 | -43.0% |
| FY2016 | $2.70 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026